CURX
Curanex Pharmaceuticals Inc Common Stock
NASDAQ: CURX · HEALTHCARE · BIOTECHNOLOGY
$0.42
+0.72% today
Updated 2026-04-30
Market cap
$12.38M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.02
Dividend yield
—
52W range
$0 – $9
Volume
5.3M
Curanex Pharmaceuticals Inc Common Stock (CURX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-85.30%
ROA
-30.00%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | $26000.00 | $-20233.00 | 17.03% | -77.82% | -77.82% |
| 2023 | $0.00 | $-19198.00 | — | — | — |
| 2024 | $0.00 | $-361506.00 | — | — | — |
| 2025 | $0.00 | $-4.23M | — | — | — |